About one in 44,000 National Collegiate Athletic Association athletes has sudden cardiac death each year, according to a new study in Circulation: Journal of the American Heart Association.
The death rate — higher than many estimates for young athletes — could influence health screening guidelines for youths in organized sports, researchers said.
According to the American Heart Association, athletic training and competition can increase the risk of sudden cardiac death in people with underlying heart disease. Various heart conditions can kill young athletes, including the most common cause — hypertrophic cardiomyopathy, an abnormal growth of heart muscle fibers.
Estimates of the number of such deaths often have been based on inconsistent data sources such as media reports, said Kimberly Harmon, M.D., study author and clinical professor at the University of Washington in Seattle. Also, some studies lack solid figures on how many young people play sports overall, which also affects risk estimates.
The new study used news reports, insurance claims and data from the NCAA, the governing body for intercollegiate sports in the United States. About 400,000 students, ages 17-23, participate in NCAA sports each year.
Researchers tracked deaths from 2004 through 2008 and identified:
Of deaths from medical causes, 56 percent (45 athletes) were cardiovascular-related sudden deaths. Of the 36 deaths that occurred during or shortly after exertion, 75 percent (27 athletes) were related to cardiac causes. In all, the study found that one in 43,770 athletes died annually of sudden cardiac death.
Among other findings:
Incidence rates often determine whether screening for young athletes should include an electrocardiogram or echocardiogram, said Harmon, a team physician at the University of Washington. "You have to revisit the whole question of whether a more extensive screening makes sense in light of these new numbers," she said. "The question is: where do you set the risk cutoff — one in 10,000, or 40,000, or 100,000?"
In a 2007 statement, the American Heart Association recommended that every athlete give a detailed personal and family medical history and have a thorough physical exam before participating in sports. If these items uncover information that raises concern, further testing may be warranted.
The European Society of Cardiology and the International Olympic Committee recommend the addition of electrocardiograms (ECG), a step that the American Heart Association panel considered unwieldy and too costly for large U.S. athlete populations.
"The American Heart Association regards cardiovascular screening for athletes as an important public health issue, for which there are compelling ethical, legal and medical grounds," said Ralph L. Sacco, M.S., M.D., president of the American Heart Association. "We strongly encourage student-athletes and other participants in organized competitive sports to be screened with a careful history, including family history, and thorough physical examination. The American Heart Association also believes healthcare professionals providing the screening should be able to order noninvasive testing when they judge it is needed."
More extensive screening might be practical if targeted at high-risk groups — for instance, basketball players, Harmon said.
Furthermore, automated external defibrillators, used to revive people whose hearts have stopped, could be placed in venues where the highest-risk sports are played, she said.
Co-authors are: Irfan Asif, M.D.; David Klossner, A.T.C., Ph.D.; and Jonathan A. Drezner, M.D. Author disclosures are on the manuscript.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.